跳至主要内容
临床试验/NCT03063424
NCT03063424Unknown不适用

Hyperventilation Versus Exercise Testing Sensitivity in Exercise Induced Asthma

Université de Sherbrooke1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2011年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
Compare the sensitivity and specificity of eucapnic voluntary hyperventilation versus exercise challenge testing on a cycle ergometer for exercise-induced bronchospasm diagnosis in established asthmatic subjects with exercise symptoms.

研究概览

简要总结

The diagnosis of exercise-induced bronchospasm (EIB) is difficult. The metacholine challenge test is not enough specific for the diagnosis of EIB. The exercise challenge test on a cycle ergometer is often use to diagnose this condition. This test has very high specificity, but not enough sensibility because the ventilation achieved during this test is often not big enough to induce a bronchospasm, especially in trained athletes. Eucapnic voluntary hyperventilation (EVH) is the recommended test of the Olympic National committee to establish the diagnosis of EIB, but there are no study comparing the sensibility and specificity of the cycle ergometer challenge test and the isocapnic hyperventilation in an establish population of asthmatics. The investigators assume that the sensitivity and specificity of EVH are higher than those of the cycle ergometer for the diagnosis of EIB in a population of asthmatics with symptoms suggestive of bronchospasm on exertion. In a population of asthmatics with exercise symptoms, what is the sensitivity and specificity of EVH and exercise challenge on a cycle ergometer for the diagnosis of EIB?

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Diagnostic
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •for the group "exercise-induced bronchospasm":
  • •The subject must have a diagnosis of asthma according to 2010 Canadian Thoracic Society consensus criteria since more then one year.
  • •The subject should have an average expiratory volume per second (FEV1) ≥ 80% of the predicted value (post bronchodilatation) at the time of the initial visit.
  • •The subject must have had a positive methacholine test at the first visit of the study demonstrating the presence of bronchial hyperreactivity.
  • •The subject must have asthma control as defined by 2010 Canadian Thoracic Society consensus, with the obvious exception of limitations related to physical activity.
  • •The subject must have at the questionnaire significant symptoms of exercise-induced bronchospasm for more than 6 months.
  • •Inclusion Criteria for the group "healthy":
  • •The subject should not have a positive history of eczema, urticaria or allergic rhinitis for life.
  • •The subject should have a FEV1 ≥ 80% of the predicted value and an FEV1 / FVC (Forced vital capacity) ratio of ≥70% at the time of the initial visit.
  • •The subject should have a negative methacholine test at the first visit of the study.
  • •The subject should not exhibit symptoms considered clinically compatible with EIB diagnosis.

排除标准

  • •Pregnant or breast-feeding women.
  • •The subject should not suffer from clinically significant concomitant diseases that may compromise the course of the study.
  • •The subject should not have taken per os or intravenously steroids in the 8 weeks prior to the study.
  • •The subject should not have experienced significant symptoms of respiratory tract infection (viral or bacterial) in the 8 weeks prior to the study.
  • •The subject must not have participated in another study during the month preceding the date of enrollment of this study.
  • •The subject should not have smoked within the last 6 months.
  • •Exclusion criteria during the study:
  • •The subject doesn't show up for all 3 visits or doesn't complete all required exams.
  • •The subject develops a respiratory tract infection, an acute exacerbation of his asthma or any other conditions that compromise his participation in the required examinations.
  • •The subject has a pre-test FEV1 of less than 80%.

研究组 & 干预措施

Healthy subjects

Other

干预措施: Eucapnic voluntary hyperventilation (Diagnostic Test)

Healthy subjects

Other

干预措施: Exercise challenge on a cycle ergometer (Diagnostic Test)

Asthmatics with EIB

Other

干预措施: Eucapnic voluntary hyperventilation (Diagnostic Test)

Asthmatics with EIB

Other

干预措施: Exercise challenge on a cycle ergometer (Diagnostic Test)

结局指标

主要结局

Compare the sensitivity and specificity of eucapnic voluntary hyperventilation versus exercise challenge testing on a cycle ergometer for exercise-induced bronchospasm diagnosis in established asthmatic subjects with exercise symptoms.

时间窗: through study completion, an average of 1 month

次要结局

  • Correlate the magnitude of exercise bronchoconstriction during EVH and exercise challenge testing on a cycle ergometer (measurement of FEV1 before and after these tests) with severity of symptoms of EIB (with questionnaires)(through study completion, an average of 1 month)
  • Correlate the magnitude of exercise bronchoconstriction during EVH and exercise challenge testing on a cycle ergometer (FEV1 before and after these tests) with severity of bronchial hyperreactivity evaluated by methacholine challenge test (MCT).(through study completion, an average of 1 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Brian Grondin-Beaudoin

Clinical Professor, Principal Investigator

Université de Sherbrooke

研究点 (1)

Loading locations...

相似试验

Hyperventilation Versus Exercise Testing Sensitivity... | 临床试验